Cargando…

Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion

Postconditioning and cyclosporine A prevent mitochondrial permeability transition pore opening providing cardioprotection during ischemia/reperfusion. Whether microvascular obstruction is affected by these interventions is largely unknown. Pigs subjected to coronary occlusion for 1 h followed by 3 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zalewski, Jaroslaw, Claus, Piet, Bogaert, Jan, Driessche, Nina Vanden, Driesen, Ronald B., Galan, Diogo T., Sipido, Karin R., Buszman, Piotr, Milewski, Krzysztof, Van de Werf, Frans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342514/
https://www.ncbi.nlm.nih.gov/pubmed/25720581
http://dx.doi.org/10.1007/s00395-015-0475-8
_version_ 1782359284149911552
author Zalewski, Jaroslaw
Claus, Piet
Bogaert, Jan
Driessche, Nina Vanden
Driesen, Ronald B.
Galan, Diogo T.
Sipido, Karin R.
Buszman, Piotr
Milewski, Krzysztof
Van de Werf, Frans
author_facet Zalewski, Jaroslaw
Claus, Piet
Bogaert, Jan
Driessche, Nina Vanden
Driesen, Ronald B.
Galan, Diogo T.
Sipido, Karin R.
Buszman, Piotr
Milewski, Krzysztof
Van de Werf, Frans
author_sort Zalewski, Jaroslaw
collection PubMed
description Postconditioning and cyclosporine A prevent mitochondrial permeability transition pore opening providing cardioprotection during ischemia/reperfusion. Whether microvascular obstruction is affected by these interventions is largely unknown. Pigs subjected to coronary occlusion for 1 h followed by 3 h of reperfusion were assigned to control (n = 8), postconditioning (n = 9) or cyclosporine A intravenous infusion 10–15 min before the end of ischemia (n = 8). Postconditioning was induced by 8 cycles of repeated 30-s balloon inflation and deflation. After 3 h of reperfusion magnetic resonance imaging, triphenyltetrazolium chloride/Evans blue staining and histopathology were performed. Microvascular obstruction (MVO, percentage of gadolinium-hyperenhanced area) was measured early (3 min) and late (12 min) after contrast injection. Infarct size with double staining was smaller in cyclosporine (46.2 ± 3.1 %, P = 0.016) and postconditioning pigs (47.6 ± 3.9 %, P = 0.008) versus controls (53.8 ± 4.1 %). Late MVO was significantly reduced by cyclosporine (13.9 ± 9.6 %, P = 0.047) but not postconditioning (23.6 ± 11.7 %, P = 0.66) when compared with controls (32.0 ± 16.9 %). Myocardial blood flow in the late MVO was improved with cyclosporine versus controls (0.30 ± 0.06 vs 0.21 ± 0.03 ml/g/min, P = 0.002) and was inversely correlated with late-MVO extent (R (2) = 0.93, P < 0.0001). Deterioration of left ventricular ejection fraction (LVEF) between baseline and 3 h of reperfusion was smaller with cyclosporine (−7.9 ± 2.4 %, P = 0.008) but not postconditioning (−12.0 ± 5.5 %, P = 0.22) when compared with controls (−16.4 ± 5.5 %). In the three groups, infarct size (β = −0.69, P < 0.001) and late MVO (β = −0.33, P = 0.02) were independent predictors of LVEF deterioration following ischemia/reperfusion (R (2) = 0.73, P < 0.001). Despite both cyclosporine A and postconditioning reduce infarct size, only cyclosporine A infusion had a beneficial effect on microvascular damage and was associated with better preserved LV function when compared with controls. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-015-0475-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4342514
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-43425142015-03-04 Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion Zalewski, Jaroslaw Claus, Piet Bogaert, Jan Driessche, Nina Vanden Driesen, Ronald B. Galan, Diogo T. Sipido, Karin R. Buszman, Piotr Milewski, Krzysztof Van de Werf, Frans Basic Res Cardiol Original Contribution Postconditioning and cyclosporine A prevent mitochondrial permeability transition pore opening providing cardioprotection during ischemia/reperfusion. Whether microvascular obstruction is affected by these interventions is largely unknown. Pigs subjected to coronary occlusion for 1 h followed by 3 h of reperfusion were assigned to control (n = 8), postconditioning (n = 9) or cyclosporine A intravenous infusion 10–15 min before the end of ischemia (n = 8). Postconditioning was induced by 8 cycles of repeated 30-s balloon inflation and deflation. After 3 h of reperfusion magnetic resonance imaging, triphenyltetrazolium chloride/Evans blue staining and histopathology were performed. Microvascular obstruction (MVO, percentage of gadolinium-hyperenhanced area) was measured early (3 min) and late (12 min) after contrast injection. Infarct size with double staining was smaller in cyclosporine (46.2 ± 3.1 %, P = 0.016) and postconditioning pigs (47.6 ± 3.9 %, P = 0.008) versus controls (53.8 ± 4.1 %). Late MVO was significantly reduced by cyclosporine (13.9 ± 9.6 %, P = 0.047) but not postconditioning (23.6 ± 11.7 %, P = 0.66) when compared with controls (32.0 ± 16.9 %). Myocardial blood flow in the late MVO was improved with cyclosporine versus controls (0.30 ± 0.06 vs 0.21 ± 0.03 ml/g/min, P = 0.002) and was inversely correlated with late-MVO extent (R (2) = 0.93, P < 0.0001). Deterioration of left ventricular ejection fraction (LVEF) between baseline and 3 h of reperfusion was smaller with cyclosporine (−7.9 ± 2.4 %, P = 0.008) but not postconditioning (−12.0 ± 5.5 %, P = 0.22) when compared with controls (−16.4 ± 5.5 %). In the three groups, infarct size (β = −0.69, P < 0.001) and late MVO (β = −0.33, P = 0.02) were independent predictors of LVEF deterioration following ischemia/reperfusion (R (2) = 0.73, P < 0.001). Despite both cyclosporine A and postconditioning reduce infarct size, only cyclosporine A infusion had a beneficial effect on microvascular damage and was associated with better preserved LV function when compared with controls. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-015-0475-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-02-27 2015 /pmc/articles/PMC4342514/ /pubmed/25720581 http://dx.doi.org/10.1007/s00395-015-0475-8 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Contribution
Zalewski, Jaroslaw
Claus, Piet
Bogaert, Jan
Driessche, Nina Vanden
Driesen, Ronald B.
Galan, Diogo T.
Sipido, Karin R.
Buszman, Piotr
Milewski, Krzysztof
Van de Werf, Frans
Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
title Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
title_full Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
title_fullStr Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
title_full_unstemmed Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
title_short Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
title_sort cyclosporine a reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342514/
https://www.ncbi.nlm.nih.gov/pubmed/25720581
http://dx.doi.org/10.1007/s00395-015-0475-8
work_keys_str_mv AT zalewskijaroslaw cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT clauspiet cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT bogaertjan cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT driesscheninavanden cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT driesenronaldb cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT galandiogot cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT sipidokarinr cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT buszmanpiotr cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT milewskikrzysztof cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion
AT vandewerffrans cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion